Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

ClinicalTrials.gov ID: NCT05808634

Public ClinicalTrials.gov record NCT05808634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 10:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multicenter, Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Efficacy of BA3182, a Bispecific Epithelial Cell Adhesion Molecule (EpCAM)/CD3 Antibody, in Patients With Advanced Adenocarcinoma

Study identification

NCT ID: NCT05808634
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: BioAtla, Inc.; Industry
Enrollment: 168 participants

Conditions and interventions

Conditions

Advanced Adenocarcinoma

Interventions

BA3182 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 13, 2023
Primary completion: Sep 14, 2028
Completion: Sep 14, 2028
Last update posted: Sep 24, 2025

2023 – 2028

United States locations

U.S. sites: 9
U.S. states: 6
U.S. cities: 8

Facility	City	State	ZIP	Site status
UC Irvine	Irvine	California	92697	Recruiting
USC Norris Comprehensive Cancer Center	Los Angeles	California	90033	Recruiting
Yale Cancer Center	New Haven	Connecticut	06511	Recruiting
Northwestern University	Chicago	Illinois	60611	Recruiting
University of Illinois	Chicago	Illinois	60612	Recruiting
Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
The Christ Hospital Cancer Center	Cincinnati	Ohio	45219	Recruiting
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
Fred Hutch Cancer Center	Seattle	Washington	98109	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05808634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 24, 2025 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05808634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →